Rosina Maar Pavia
Corporate Officer/Principal at StratWorks LLC
Profile
Prior to joining Pappas in 2000, Dr. Pavia held senior management positions at contract research organizations for seven years, including as Vice President, Clinical Operations and Senior Vice President, Strategic Planning for Quintiles Transnational Corporation.
She managed the global clinical development program of Actonel, and oversaw the clinical components of projects leading to the approval of Actos, Aggrastat, Reopro, and Xeloda.
Dr. Pavia is the founder and Managing Director of StratWorks, LLC, a strategic consulting company focused on assisting biopharmaceutical companies with strategy, M&A, product acquisition and product development.
Previously, she was the Corporate Medical Director of a biotechnology company specializing in oncology immunotherapies.
Dr. Pavia received her board certification by the American Board of Internal Medicine in 1993.
Dr. Pavia received her BS in Health System from the School of Industrial Engineering at the Georgia Institute of Technology, her MD from the Morehouse School of Medicine, and her Executive MBA from the Kenan-Flagler Business School of the University of North Carolina at Chapel Hill.
She completed her post-doctorate training in Internal Medicine at Emory University.
Rosina Maar Pavia active positions
Companies | Position | Start |
---|---|---|
StratWorks LLC | Corporate Officer/Principal | 2003-12-31 |
Former positions of Rosina Maar Pavia
Companies | Position | End |
---|---|---|
Bayhill Therapeutics, Inc.
Bayhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bayhill Therapeutics, Inc. develops and commercializes therapeutics. Its technology is BHT-DNA. The firm is a clinical-stage biopharmaceutical company leveraging its proprietary therapeutic BHT-DNA platform to develop a pipeline of novel and targeted treatment candidates for autoimmune diseases. Bayhill Therapeutics was founded by Lawrence Steinman, Hideki Garren, William H. Robinson and Paul J. Utz in 2001 and is headquartered in Palo Alto, CA. | Director/Board Member | 2013-12-25 |
Quintiles Transnational Corp.
Quintiles Transnational Corp. Miscellaneous Commercial ServicesCommercial Services Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC. | Corporate Officer/Principal | 1999-12-31 |
Lumena Pharmaceuticals, Inc.
Lumena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lumena Pharmaceuticals, Inc. developed oral therapeutics for rare liver diseases. The firm was engaged in the development and commercialization of novel products for rare cholestatic liver diseases and serious metabolic disorders, such as nonalcoholic steatohepatitis. The company was founded by Bronislava Gedulin and Michael G. Grey in January 2011 and was headquartered in San Diego, CA. | Director/Board Member | - |
SYNDAX PHARMACEUTICALS, INC. | Director/Board Member | - |
Training of Rosina Maar Pavia
Georgia Institute of Technology | Undergraduate Degree |
Morehouse School of Medicine | Doctorate Degree |
The University of North Carolina at Charlotte | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
SYNDAX PHARMACEUTICALS, INC. | Health Technology |
Private companies | 4 |
---|---|
Quintiles Transnational Corp.
Quintiles Transnational Corp. Miscellaneous Commercial ServicesCommercial Services Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC. | Commercial Services |
Bayhill Therapeutics, Inc.
Bayhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bayhill Therapeutics, Inc. develops and commercializes therapeutics. Its technology is BHT-DNA. The firm is a clinical-stage biopharmaceutical company leveraging its proprietary therapeutic BHT-DNA platform to develop a pipeline of novel and targeted treatment candidates for autoimmune diseases. Bayhill Therapeutics was founded by Lawrence Steinman, Hideki Garren, William H. Robinson and Paul J. Utz in 2001 and is headquartered in Palo Alto, CA. | Health Technology |
Lumena Pharmaceuticals, Inc.
Lumena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lumena Pharmaceuticals, Inc. developed oral therapeutics for rare liver diseases. The firm was engaged in the development and commercialization of novel products for rare cholestatic liver diseases and serious metabolic disorders, such as nonalcoholic steatohepatitis. The company was founded by Bronislava Gedulin and Michael G. Grey in January 2011 and was headquartered in San Diego, CA. | Health Technology |
StratWorks LLC |
- Stock Market
- Insiders
- Rosina Maar Pavia